Gilead Sciences
GILD
#98
Rank
โ‚น16.182 T
Marketcap
โ‚น13,038
Share price
2.22%
Change (1 day)
37.11%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): โ‚น601.71

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is โ‚น640.81. In 2024 the company made an earnings per share (EPS) of โ‚น35.55 a decrease over its 2023 EPS that were of โ‚น425.65.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น601.711592.64%
2024โ‚น35.55-91.65%
2023โ‚น425.6523.98%
2022โ‚น343.32-25.86%
2021โ‚น463.074850%
2020โ‚น9.35-97.64%
2019โ‚น396.650.9%
2018โ‚น393.1218.71%
2017โ‚น331.16-64.88%
2016โ‚น942.97-18.45%
2015โ‚น1,15655.28%
2014โ‚น744.65296.02%
2013โ‚น188.0317.89%
2012โ‚น159.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,042 62.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น127.23-80.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น223.73-65.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,154 236.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,341 109.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น826.04 28.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น512.65-20.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1,447 125.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น683.87 6.72%๐Ÿ‡บ๐Ÿ‡ธ USA